Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Armand

Showing results (61-70 of 205) with videos related to

Pageof 21
Sort By:
Bulletin Du Cancer|March 16, 2001
[Carcinoma of the nasopharynx]A Hasbini, E Raymond, E Cvitkovic, et al.
La Nouvelle Presse Medicale|August 5, 1981
[Is there a preventive method useful for cerebral metastases of anaplastic bronchial cancers?]T D Nguyen, A Pons, J P Armand, et al.
Cancer Research|February 15, 1992
Quantitative mapping of 4'-iododeoxyrubicin in metastatic squamous cellcarcinoma by secondary ion mass spectrometry (SIMS) microscopyP Fragu, J Klijanienko, D Gandia, et al.
Science (New York, N.Y.)|February 1, 1974
Inhibition of cellular mediated immunity in marihuana smokersG G Nahas, N Suciu-Foca, J P Armand, et al.
Neuroimaging Clinics of North America|August 1, 1997
Magnetization transfer imaging in AIDS-related brain diseasesV Dousset, J P Armand, P Huot, et al.
Nouvelle Revue Francaise D'Hematologie; Blood Cells|January 1, 1977
[Serologic study of the family of a child having immunoblastic lymphosarcoma]J Bertoglio, G Souillet, J P Armand, et al.
Bulletin Du Cancer|January 1, 1989
[Potentialities of fluorine-19 and phosphorus-31 NMR for studying the metabolism and pharmacokinetics of fluorinated or phosphoric antineoplastic agents]R Martino, M C Malet-Martino, J P Armand, et al.
Bulletin Du Cancer|September 25, 2001
[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer]M Ducreux, K Fizazi, J F Seitz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancerJ Verweij, D Gandia, A S Planting, et al.
American Journal of Clinical Oncology|June 1, 1996
Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neckM E Bensmaine, N Azli, C Domenge, et al.
Pageof 21

Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
Bulletin Du Cancer|March 16, 2001
[Carcinoma of the nasopharynx]A Hasbini, E Raymond, E Cvitkovic, et al.
La Nouvelle Presse Medicale|August 5, 1981
[Is there a preventive method useful for cerebral metastases of anaplastic bronchial cancers?]T D Nguyen, A Pons, J P Armand, et al.
Cancer Research|February 15, 1992
Quantitative mapping of 4'-iododeoxyrubicin in metastatic squamous cellcarcinoma by secondary ion mass spectrometry (SIMS) microscopyP Fragu, J Klijanienko, D Gandia, et al.
Science (New York, N.Y.)|February 1, 1974
Inhibition of cellular mediated immunity in marihuana smokersG G Nahas, N Suciu-Foca, J P Armand, et al.
Neuroimaging Clinics of North America|August 1, 1997
Magnetization transfer imaging in AIDS-related brain diseasesV Dousset, J P Armand, P Huot, et al.
Nouvelle Revue Francaise D'Hematologie; Blood Cells|January 1, 1977
[Serologic study of the family of a child having immunoblastic lymphosarcoma]J Bertoglio, G Souillet, J P Armand, et al.
Bulletin Du Cancer|January 1, 1989
[Potentialities of fluorine-19 and phosphorus-31 NMR for studying the metabolism and pharmacokinetics of fluorinated or phosphoric antineoplastic agents]R Martino, M C Malet-Martino, J P Armand, et al.
Bulletin Du Cancer|September 25, 2001
[Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer]M Ducreux, K Fizazi, J F Seitz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancerJ Verweij, D Gandia, A S Planting, et al.
American Journal of Clinical Oncology|June 1, 1996
Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neckM E Bensmaine, N Azli, C Domenge, et al.
Pageof 21